Ventilator Hyperinflation and Manual Rib Cage Compression
Comparison Between Ventilator Hyperinflation and Manual Rib Cage Compression: Randomized Crossover Trial
1 other identifier
interventional
30
0 countries
N/A
Brief Summary
This is a randomized crossover trial to evaluate the effects of thoracic compression applied alone or in association with hyperinflation maneuver with the ventilator. In addition, the mobilized volume and peak expiratory flow resulting from both maneuvers will be evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2014
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 28, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 11, 2017
CompletedFirst Submitted
Initial submission to the registry
August 6, 2018
CompletedFirst Posted
Study publicly available on registry
August 15, 2018
CompletedAugust 15, 2018
August 1, 2018
7 days
August 6, 2018
August 9, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Static compliance of respiratory system
Compliance was assessed through the occlusion maneuver at the end of inspiration, considering tidal volume, plateau pressure and PEEP. Three measurements were taken at each moment, the mean being used.
Baseline (before), immediately after ventilator hyperinflation or rib cage compression and five minutes after aspiration
Total Resistance of respiratory system
The total resistance of the respiratory system was evaluated through the occlusion maneuver at the end of the inspiration, considering the resistive pressure, measured by the difference between the maximum plateau pressure. Three measurements were taken at each moment, the mean being used.
Baseline (before), immediately after ventilator hyperinflation or rib cage compression and five minutes after aspiration
Airway Resistance
The airway resistance was assessed by means of the occlusion maneuver at the end of the inspiration, considering the rapid fall of the pressure immediately after the occlusion, measured by the difference between the maximum pressure and P1. Three measurements were taken at each moment, the mean being used.
Baseline (before), immediately after ventilator hyperinflation or rib cage compression and five minutes after aspiration
Peak expiratory flow
The peak expiratory flow was evaluated through passive expiration, being considered the greatest value of the flow in the expiratory phase.
Baseline (before), immediately after ventilator hyperinflation or rib cage compression and five minutes after aspiration
Study Arms (2)
Expiratory Rib Cage Compression
ACTIVE COMPARATORExpiratory rib cage compression was performed in 6 sets of 6 cycles, with 1 cycle interval. Ventilatory mode and parameters were maintained.
Compression + Ventilator Hyperinflation
ACTIVE COMPARATORExpiratory rib cage compression was performed in 6 sets of 6 cycles, with 1 cycle interval. Ventilator hyperinflation was performed by increasing the inspiratory pressure to every 5 cmH2O until the total pressure reached 40 cmH2O, remaining the same.
Interventions
Compression was performed in 6 sets of 6 cycles, with 1 cycle interval. Ventilatory mode and parameters were maintained.
Mechanical ventilator hyperinflation was performed by increasing the inspiratory pressure to every 5 cmH2O until the total pressure reached 40 cmH2O, remaining the same. In Expiratory Rib Cage Compression associated with ventilator hyperinflation, thoracic compression maneuver was performed at the end of inspiration, at the exact moment of cycling.
Eligibility Criteria
You may qualify if:
- patients under mechanical ventilation
- diagnosis of pulmonary infection
- hypersecretive
You may not qualify if:
- haemodynamic instability (heart rate \> 130 bpm and mean arterial pressure \< 60 mmHg)
- acute bronchospasm
- acute respiratory distress syndrome
- untreated pneumothorax
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
LUCIANO M CHICAYBAN, MSc
Brazilian Institute of Higher Education of Censa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 6, 2018
First Posted
August 15, 2018
Study Start
November 28, 2014
Primary Completion
December 5, 2014
Study Completion
July 11, 2017
Last Updated
August 15, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share